Glucagon-like peptide-1 receptor regulates thromboxane-induced human platelet activation

Glucagon-like peptide-1 receptor regulates thromboxane-induced human platelet activation

Bibliographic Details
Main Authors:	Cahill, KN, Amin, T, Boutaud, O, Hodson, D, Et al.
Format:	Journal article
Language:	English
Published:	Elsevier 2022

Similar Items

Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
by: Markus Ammann, et al.
Published: (2023-09-01)

Induced Human Regulatory T Cells Express the Glucagon-like Peptide-1 Receptor
by: Anna K. O. Rode, et al.
Published: (2022-08-01)

Correction: Human Thromboxane A Receptor Genetic Variants: , and “In Platelet” Analysis.
by: Scott Gleim, et al.
Published: (2013-01-01)

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
by: Seungah Lee, et al.
Published: (2017-03-01)

New insights into the regulation of glucagon secretion by glucagon-like peptide-1.
by: Gromada, J, et al.
Published: (2004)

Equine glucagon-like peptide-1 receptor physiology
by: Murad H. Kheder, et al.
Published: (2018-01-01)

Investigating the Glucagon Receptor and Glucagon-Like Peptide 1 Receptor Activity of Oxyntomodulin-Like Analogues in Male Wistar Rats
by: Samantha L. Price, MRes, et al.
Published: (2015-12-01)

Rivaroxaban reduces thromboxane induced platelet aggregation - the forgotten compass arm?
by: Lisa Dannenberg, et al.
Published: (2021-11-01)

Glucagon-Like Peptide-1 Receptor Regulates Macrophage Migration in Monosodium Urate-Induced Peritoneal Inflammation
by: Jun Chen, et al.
Published: (2022-01-01)

Effect of glucagon-like peptide-1 receptor agonists in patients with psoriasis
by: Marwa R. Al-Badri, et al.
Published: (2014-04-01)

Association of glucagon‐like peptide‐1 receptor‐targeted imaging probe with in vivo glucagon‐like peptide‐1 receptor agonist glucose‐lowering effects
by: Takaaki Murakami, et al.
Published: (2020-11-01)

Immunohistochemical Glucagon-like Peptide-1 Receptor Expression in Human Insulinomas
by: Tiina Vesterinen, et al.
Published: (2023-10-01)

Glucagon-Like Peptide-1
by: Joel P. Giblett, BM, BSc, et al.
Published: (2016-06-01)

INHIBITION OF THROMBOXANE SYNTHESIS AND OF ARACHIDONATE-INDUCED PLATELET BEHAVIOR IN PLATELETS FROM DIFFERENT INDIVIDUALS
by: Heptinstall, S, et al.
Published: (1981)

Human thromboxane A2 receptor genetic variants: in silico, in vitro and "in platelet" analysis.
by: Scott Gleim, et al.
Published: (2013-01-01)

Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research
by: Levin PA, et al.
Published: (2017-04-01)

Nephroprotective potential of glucagon-like peptide-1 receptor agonists
by: Minara S. Shamkhalova, et al.
Published: (2020-04-01)

Pharmacogenetics of Glucagon-like-peptide-1 receptor in diabetes management
by: Mariya Kalinkova, et al.
Published: (2023-06-01)

Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
by: Yu Mi Kang, et al.
Published: (2016-06-01)

How glucagon-like peptide 1 receptor agonists work
by: Christine Rode Andreasen, et al.
Published: (2021-07-01)

Corrigendum: Glucagon-Like Peptide-1 Receptor Regulates Macrophage Migration in Monosodium Urate-Induced Peritoneal Inflammation
by: Jun Chen, et al.
Published: (2022-03-01)

Architecture of androgen receptor pathways amplifying glucagon-like peptide-1 insulinotropic action in male pancreatic β cells
by: Xu, W, et al.
Published: (2023)

Revealing the tissue-level complexity of endogenous glucagon-like peptide-1 receptor expression and signaling
by: Ast, J, et al.
Published: (2023)

Expression of the glucagon-like peptide-1 receptor and its role in regulating autophagy in endometrial cancer
by: Ranka Kanda, et al.
Published: (2018-06-01)

Correction: Human Thromboxane A2 Receptor Genetic Variants: In Silico, In Vitro and “In Platelet” Analysis
Published: (2013-01-01)

Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Hypoglycemia
by: Daria Ja’arah, et al.
Published: (2021-10-01)

Glucagon-like peptide-1 receptor agonists in patients treated with antipsychotics
by: A. Delgado, et al.
Published: (2021-04-01)

Glucagon-Like Peptide-1 Receptor Agonists for Chronic Weight Management
by: Magda Wojtara, et al.
Published: (2023-01-01)

The potential of glucagon-like peptide-1 receptor agonists in heart failure
by: Frederik Flindt Kreiner, et al.
Published: (2022-09-01)

Application of glucagon-like peptide-1 receptor antagonists in fibrotic diseases
by: Fuxun Yang, et al.
Published: (2022-08-01)

Revealing the tissue-level complexity of endogenous glucagon-like peptide-1 receptor expression and signaling
by: Julia Ast, et al.
Published: (2023-01-01)

Canine platelets express functional Toll-like receptor-4: lipopolysaccharide-triggered platelet activation is dependent on adenosine diphosphate and thromboxane A2 in dogs
by: Ronald H. L. Li, et al.
Published: (2019-07-01)

Glucagon-Like Peptide-1 Receptor Agonists as Potential Myelination-Inducible and Anti-Demyelinating Remedies
by: Kazunori Sango, et al.
Published: (2022-07-01)

Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors.
by: Gromada, J, et al.
Published: (1997)

Glucagon-like Peptide-1 Receptor Activation Reduces Pulmonary Vein Arrhythmogenesis and Regulates Calcium Homeostasis
by: Chao-Shun Chan, et al.
Published: (2023-08-01)

The effects of Fc fusion protein glucagon-like peptide-1 and glucagon dual receptor agonist with different receptor selectivity in vivo studies
by: Peng Jiang, et al.
Published: (2024-05-01)

Molecular insights into ago-allosteric modulation of the human glucagon-like peptide-1 receptor
by: Zhaotong Cong, et al.
Published: (2021-06-01)

Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potential.
by: Gromada, J, et al.
Published: (2004)

The Road towards Triple Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor - An Update
by: Agnieszka Jakubowska, et al.
Published: (2024-02-01)

Glucagon-like peptide 1 receptor activation: anti-inflammatory effects in the brain
by: Yolanda Diz-Chaves, et al.
Published: (2024-01-01)